Beyond the Boundaries of Autism

4 year old Olivia received stem cell therapies for Autism and sees incredible improvements.

When 4-year-old Olivia was diagnosed with Autism, her parents began a long journey of learning, advocacy, and hope. That journey led them to explore IV exosome infusions, pursued thoughtfully and performed by an experienced regenerative physician alongside traditional developmental care.

Before treatment, Olivia underwent a comprehensive evaluation with Zaki Anwar, MD. This process included a review of diagnostic assessments, relevant medical records, and her developmental history to determine an appropriate treatment plan.

Six months after beginning treatment, Olivia’s progress exceeded her family’s hopes. Her ATEC (Autism Treatment Evaluation Checklist) scores improved by 40% compared to her pre-treatment assessment, with meaningful gains across Speech and Language, Sociability, Sensory Awareness and Cognition, and Physical and Behavioral Health.

“My daughter is more present, more talkative, and more connected than ever before,” her mother Lauren shares with a smile.

Exosomes, sourced from Mesenchymal Stem Cells, have been shown to influence processes such as neuroinflammation and neurogenesis—areas relevant to neurodevelopmental conditions. Research published through the National Library of Medicine indicates that exosomes can help regulate disrupted cellular communication.

Olivia has shown meaningful progress in several areas:

• Sleep patterns have become more consistent, and she now sleeps through the night

• Her speech has progressed from single words to regularly using 3+-word sentences

• Potty training has accelerated, with clear communication when she needs to go and less assistance required

• She is more communicative, with a noticeably happier mood overall

• She follows directions more consistently 

Measurable progress has also been noted at school and in therapy. Her speech therapist noticed a great difference, saying she was “blown away” by Olivia’s growth, engagement, and how much they now accomplish during sessions, while her teacher reports smoother transitions and strong joint attention.

While regenerative therapies are not cures and outcomes vary by individual, Olivia’s story illustrates how these options may provide support and offer a greater quality of life for some children and families navigating autism.

All care was delivered at Chicago Stem Cell Therapy in Frankfort, a Joint Commission–accredited (JCAHO) facility, reflecting adherence to nationally recognized standards for patient safety, clinical oversight, and quality care.  To schedule an evaluation or learn more, call or text 815-464-7212 or visit www.ChicagoStemCellTherapy.com